Investors in Novartis can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Per share the analysts expect a dividend of 3.6 CHF per share. The dividend yield is then 3.87 percent. The average dividend yield of the pharmaceutical companies equals a relatively high 2.07 percent.
Tomorrow Novartis will publish its past quarters results. For this year the company, based in revenue will be around 46.85 billion CHF. This is according to the average of the analysts' estimates. This is slightly lower than 2022's revenue of 51.74 billion CHF.
Novartis Copenhagen © Novartis |
The analysts expect for 2023 a net profit of 13.6 billion CHF. For this year the consensus of the result per share is a profit of 6.48 CHF. So the price/earnings-ratio equals 14.34.
Based on the current number of shares Novartis 's market capitalization equals 207.65 billion CHF.
On Friday, the stock closed at 92.91 CHF.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.